The Health Ministry of the archipelago off of Africa’s east coast said Monday that the number of active cases had more than doubled since last week to 2,486 people, and 37% of those have received two vaccine doses. Cases are also surging in the Maldives, another Indian Ocean island nation that’s a popular tourism destination. In Seychelles, Sinopharm shots were issued to 57% of those who were fully inoculated and the rest with Covishield, a vaccine made in India under a license from AstraZeneca Plc. As of May 8 no one who had contracted Covid while being vaccinated had died, Seychelles News Agency reported, citing the minister for foreign affairs and tourism... Daniel Lucey, clinical professor of medicine at Dartmouth Geisel School of Medicine, said in a blog last week that data on genetic sequencing are not yet available for infections in Seychelles in April. Still, the B.1.351 variant, first identified in South Africa late last year, was found in the Seychelles in February, he said. AstraZeneca’s vaccine appeared to be less effective against that variant in a study, and South Africa halted plans to use those injections.